The Citigate Dewe Rogerson Life Sciences team recently co-sponsored the Future of Healthcare Investor Forum alongside J.P. Morgan and Numis and industry partners BIA and OneNucleus.
We all know that content is king when devising a communications strategy, especially for a traditional media programme. So why is it any different for social media, or at least on the face of it?
If you’re an emerging life sciences company you may be feeling rather unloved at the moment, with pharma giant Pfizer and UK champion AstraZeneca being the key focus of media scrutiny.